<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890108</url>
  </required_header>
  <id_info>
    <org_study_id>EANC-1</org_study_id>
    <nct_id>NCT02890108</nct_id>
  </id_info>
  <brief_title>Effect of Consumption of Non Caloric Sweeteners and Insulin Sensibility</brief_title>
  <official_title>Effect of Consumption of Non Caloric Sweeteners and Insulin Sensibility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Nutrición y Tecnología de los Alimentos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Nutrición y Tecnología de los Alimentos</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the effect of acute consumption of two carbonated drinks, sweetened
      with sugar or with non-caloric sweeteners, over the insulin response of healthy adults who
      normally consumed foods or drinks that contain non-caloric sweeteners
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During the last decades there has been a sustained increase in prevalence of overweight and
      obesity and, along with it, of chronic noncommunicable diseases. There have been addressed
      various management strategies, including sugar replacement for Non-caloric Artificial
      Sweeteners (NAS). Nevertheless, in several cohort studies it has found the opposite effect,
      it has observed associations between the consumption of NAS with greater weight gain and
      increased risk of type 2 diabetes and metabolic syndrome. In clinical trials, in both humans
      and mice, there has been greater association with glucose intolerance, being 3 possible
      mechanisms: 1) dysbiosis of the intestinal microbiota; 2) altered regulation of appetite
      cephalic phase and secretion of glucagon like peptide-1 (GLP-1); and 3) increased intestinal
      glucose absorption via increased Sodium-Glucose Linked Transporter-1 (SGLT-1) and Glucose
      transporter 2 (GLUT2), transporters to glucose absorption.

      In the following review the major findings in the literature regarding the consumption of NAS
      and its deleterious effects on human health will be studied.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensibility</measure>
    <time_frame>Measured at 6 intervals (3 times sugar sweetened beverages and 3 times artificially sweetened beverages), separated at least by 1 week from each other. All the tests must be assessed during 10 weeks utmost.</time_frame>
    <description>One insulinemic curve will be conducted to assess the effect of consumption of artificially sweetened beverage on insulin response compared to the consumption of a sugar sweetened drink.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemic response</measure>
    <time_frame>Measured at 6 intervals (3 times sugar sweetened beverages and 3 times artificially sweetened beverages), separated at least by 1 week from each other. All the tests must be assessed during 10 weeks utmost.</time_frame>
    <description>One glycemic curve will be conducted to assess the effect of consumption of artificially sweetened beverage on glycemic response compared to the consumption of a sugar sweetened drink.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Insulin Sensitivity</condition>
  <arm_group>
    <arm_group_label>Sugar sweetened beverages</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive, in 3 different ocassions, 350cc (1 can) of a sugar sweetened beverage, that contain 38,7 grams of carbs and 154 kcal, separated by at least 1 week each one</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Artificially sweetened beverage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive, in 3 different ocassions, 350cc (1 can) of a artificially sweetened beverage, that contain 84 mg of Aspartame, 56 mg of Acesulfame K and 0,7 kcal, separated by at least 1 week each one</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sugar sweetened beverages</intervention_name>
    <description>350 cc (1 can) of sugar sweetened beverage</description>
    <arm_group_label>Sugar sweetened beverages</arm_group_label>
    <other_name>Sugar sweetened drinks</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Artificially sweetened beverages</intervention_name>
    <description>350 cc (1 can) of artificially sweetened beverage</description>
    <arm_group_label>Artificially sweetened beverage</arm_group_label>
    <other_name>Artificially sweetened drinks</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index (BMI) between 18,5 - 24,9 kg/mt2

          -  Healthy men or women

          -  Fasting plasma glucose &lt; 100 mg/dL

        Exclusion Criteria:

          -  Consumption of drugs affecting glucose metabolism, antihypertensives or lipid lowering

          -  Subjects with insulin resistance, type 1 or 2 diabetes, dyslipidemia, hypertension;
             heart, liver or kidney disease, respiratory failure, stroke, or any chronic illness.

          -  Pregnant women.

          -  Being treated to gain or lose weight.

          -  History of recurrent episodes of acute diarrhea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romina A Goza Ferreira, Magister c</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Nutrition and Tecnology of Food, University of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandra Hirsch Birn, Magister</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Nutrition and Tecnology of Food, University of Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Romina A Goza Ferreira, Magister c</last_name>
    <phone>+56950088329</phone>
    <email>rominagoza@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandra Hirsch Birn, Magister</last_name>
    <phone>+56229781495</phone>
    <phone_ext>+56229781499</phone_ext>
    <email>shirsch@inta.uchile.cl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Nutrition and Tecnology of Food, University of Chile</name>
      <address>
        <city>Santiago</city>
        <state>Metropolitan region</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Verónica Cornejo Espinoza, Director</last_name>
      <phone>+56229781 410</phone>
      <email>vcornejo@inta.uchile.cl</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Hirsch Birn, Academic</last_name>
      <phone>+56229781495</phone>
      <phone_ext>+56229781499</phone_ext>
      <email>shirsch@inta.uchile.cl</email>
    </contact_backup>
    <investigator>
      <last_name>Romina A Goza Ferreira, Magister c</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Hirsch Birn, Magister</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gladys Barrera Acevedo, Magister</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <reference>
    <citation>Pan A, Malik VS, Hao T, Willett WC, Mozaffarian D, Hu FB. Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. Int J Obes (Lond). 2013 Oct;37(10):1378-85. doi: 10.1038/ijo.2012.225. Epub 2013 Jan 15.</citation>
    <PMID>23318721</PMID>
  </reference>
  <reference>
    <citation>de Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr. 2011 Jun;93(6):1321-7. doi: 10.3945/ajcn.110.007922. Epub 2011 Mar 23.</citation>
    <PMID>21430119</PMID>
  </reference>
  <reference>
    <citation>Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR Jr. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2009 Apr;32(4):688-94. doi: 10.2337/dc08-1799. Epub 2009 Jan 16.</citation>
    <PMID>19151203</PMID>
  </reference>
  <reference>
    <citation>Pepino MY. Metabolic effects of non-nutritive sweeteners. Physiol Behav. 2015 Dec 1;152(Pt B):450-5. doi: 10.1016/j.physbeh.2015.06.024. Epub 2015 Jun 19. Review.</citation>
    <PMID>26095119</PMID>
  </reference>
  <reference>
    <citation>Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab. 2013 Sep;24(9):431-41. doi: 10.1016/j.tem.2013.05.005. Epub 2013 Jul 10.</citation>
    <PMID>23850261</PMID>
  </reference>
  <reference>
    <citation>Feijó FM, Ballard CR, Foletto KC, Batista BAM, Neves AM, Ribeiro MFM, Bertoluci MC. Saccharin and aspartame, compared with sucrose, induce greater weight gain in adult Wistar rats, at similar total caloric intake levels. Appetite. 2013 Jan;60(1):203-207. doi: 10.1016/j.appet.2012.10.009. Epub 2012 Oct 23.</citation>
    <PMID>23088901</PMID>
  </reference>
  <reference>
    <citation>Anton SD, Martin CK, Han H, Coulon S, Cefalu WT, Geiselman P, Williamson DA. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite. 2010 Aug;55(1):37-43. doi: 10.1016/j.appet.2010.03.009. Epub 2010 Mar 18.</citation>
    <PMID>20303371</PMID>
  </reference>
  <reference>
    <citation>Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. Epub 2014 Sep 17.</citation>
    <PMID>25231862</PMID>
  </reference>
  <reference>
    <citation>Palmnäs MS, Cowan TE, Bomhof MR, Su J, Reimer RA, Vogel HJ, Hittel DS, Shearer J. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PLoS One. 2014 Oct 14;9(10):e109841. doi: 10.1371/journal.pone.0109841. eCollection 2014.</citation>
    <PMID>25313461</PMID>
  </reference>
  <reference>
    <citation>Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care. 2009 Dec;32(12):2184-6. doi: 10.2337/dc09-1185. Epub 2009 Oct 6.</citation>
    <PMID>19808921</PMID>
  </reference>
  <reference>
    <citation>Temizkan S, Deyneli O, Yasar M, Arpa M, Gunes M, Yazici D, Sirikci O, Haklar G, Imeryuz N, Yavuz DG. Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes. Eur J Clin Nutr. 2015 Feb;69(2):162-6. doi: 10.1038/ejcn.2014.208. Epub 2014 Oct 1.</citation>
    <PMID>25271009</PMID>
  </reference>
  <reference>
    <citation>Pepino MY, Tiemann CD, Patterson BW, Wice BM, Klein S. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care. 2013 Sep;36(9):2530-5. doi: 10.2337/dc12-2221. Epub 2013 Apr 30.</citation>
    <PMID>23633524</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>August 31, 2016</last_update_submitted>
  <last_update_submitted_qc>August 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Nutrición y Tecnología de los Alimentos</investigator_affiliation>
    <investigator_full_name>Romina Goza Ferreira</investigator_full_name>
    <investigator_title>magister thesis student in adult clinical nutrition</investigator_title>
  </responsible_party>
  <keyword>High-Intensity Sweeteners</keyword>
  <keyword>Non-Nutritive Sweeteners</keyword>
  <keyword>Artificial sweeteners</keyword>
  <keyword>Glucose intolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>All the data is confidential and only will be show if ethics committee ask for it</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>May 15, 2017</submitted>
    <returned>October 6, 2017</returned>
    <submitted>December 12, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

